Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Paul Matuszewski

Orthopaedic Surgery Lexington, KY Medical Doctor

NPI 1154649770 CMS profile 1348051

Uk Orthopaedics, 740 S. Limestone, Lexington, KY 40536

Open in the dashboard

General payments

$370,022

438 records reported · program years 2019–2025

Research payments

$6,500

Paid to them · 6 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$264,340 paid to institutions, not to them · program years 2019–2024

Through program year 2025, Paul Matuszewski of Lexington, KY is reported in the CMS Open Payments database as having received $370,022 across 438 general payments and $6,500 in research payments paid to them. Separately, studies naming them as principal investigator received $264,340 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 96th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

11 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $99,577 101
2024 General $50,701 115
2023 General $45,160 45
2022 General $62,578 68
2022 Research $1,750 1
2021 General $81,475 73
2021 Research $2,750 3
2020 General $19,251 16
2020 Research $1,000 1
2019 General $11,280 20
2019 Research $1,000 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Paul Matuszewski
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Paul Matuszewski were reported at $99,577. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Paul Matuszewski Orthopaedic Surgery median Middle half National median
2019 $11,280 $644 $140–$2,844 $163
2020 $19,251 $312 $75–$1,860 $114
2021 $81,475 $520 $117–$2,495 $132
2022 $62,578 $598 $128–$2,731 $149
2023 $45,160 $461 $128–$2,264 $160
2024 $50,701 $497 $134–$2,475 $164
2025 $99,577 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Stryker Corporation $264,721 314 payments
  2. Bone Support Inc. $35,020 9 payments
  3. MY01 Inc. $21,994 23 payments
  4. Smith+Nephew, Inc. $21,820 36 payments
  5. Globus Medical, Inc. $8,410 16 payments
  6. NuVasive, Inc. $5,000 1 payment
  7. Integra LifeSciences Corporation $4,113 8 payments
  8. Synthes GmbH $3,560 6 payments
  9. Austin Medical Ventures Inc $3,150 2 payments
  10. Medical Device Business Services, Inc. $836 4 payments
  11. Other $1,399 19 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $270,451 78 payments
  2. Travel and Lodging $47,167 98 payments
  3. Honoraria $20,250 10 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $13,340 2 payments
  5. Food and Beverage $11,583 245 payments
  6. Grant $5,000 1 payment
  7. Compensation for serving as faculty or as a speaker for a medical education program $2,000 2 payments
  8. Education $231 2 payments
Products named General payments · program years 2019–2025
  1. HOFFMANN Trauma & Extremeties $145,393 117 payments
  2. CERAMENTBONE VOID FILLER $35,020 9 payments
  3. CERAMENT G $35,020 9 payments
  4. VARIAX $25,561 23 payments
  5. MY01 Continuous Compartmental Pressure Monitor $21,994 23 payments
  6. T2 ALPHA $20,733 12 payments
  7. HOFFMANN Trauma & Extremeties $17,511 15 payments
  8. GAMMA $17,033 24 payments
  9. PRO $16,286 14 payments
  10. AXSOS $16,186 18 payments
  11. Other $170,569 262 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Bone Support Inc. $6,500 6 payments

Billing to Medicare

Part B · data year 2024 · 56 billing codes

Paid by Medicare

$56,872

Medicare's payments for the services billed

Medicare patients

86

Average age 73

Services billed

172

58 women, 28 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Depression 47%
Osteoporosis 44%
Diabetes 43%
COPD 42%
Ischemic heart disease 37%
Chronic kidney disease 34%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

444 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Kentucky

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record